Search result for Food and Drug
40% of Pesticide Products in Nigeria are Banned by the EU
The National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria has said that 40 percent of registered brands of pesticide products in Nigeria have been banned by the European Union and hence are harming people, animals, and the Nigerian environment.
Nigeria is a so...
COVID-19 SELF-TEST KITS GIVEN CONDITIONAL APPROVAL IN S. KOREA
Highlights –
- COVID-19 self-test kits given conditional approval in S. Korea.
- The test kits are developed by two biotech firms, SD Biosensor and Humasis.
- The tool however has a low accuracy rate compared to PCR tests.
- The te...
S. KOREAN EXPERTS TELL PFIZER VACCINES SHOWED A 95% EFFICACY RATE
Highlights –
- S. Korean experts tell Pfizer vaccines showed a 95% efficacy rate.
- The expert panel is the first step of three separate independent evaluations.
- The panel is said to have reviewed Pfizer's clinical trials conducted in...
SEOUL DISCTRICT COURT ACQUITTED KOLON LIFE EXECUTIVES ON FRIDAY
Highlights –
- Seoul District Court acquitted Kolon Life executives on Friday.
- The two executives allegedly made fraudulent reports in its gene therapy drug.
- A senior director at the clinical development team is made to pay a fine of 5 ...
S. KOREA APPROVES CELLTRION INC.’S COVID-19 ANTIBODY TREATMENT WITH CONDITIONS
Highlights –
- S. Korea approves Celltrion Inc.’s COVID-19 antibody treatment with conditions.
- The country’s drug safety agency has given conditional marketing authorization of CT-P59.
- Celltrion plans to conduct a global pha...
JAPAN HEALTH MINISTRY REPORTS LESS THAN 1% OF PEOPLE HAD COVID-19 ANTIBODIES
Highlights –
- Japan Health Ministry reports less than 1% of people had COVID-19 antibodies.
- The govt. conducted tests of about 15,000 individuals at the end of 2020.
- Five prefectures participated in the antibodies test.
- In T...
S. KOREAN GOVT. TO HAVE COVID-19 VACCINATIONS TO 70% OF ITS POPULATION BY SEPT.
Highlights –
- S. Korean govt. to have COVID-19 vaccinations to 70% of its population by Sept.
- The country is said to start its first vaccination next month.
- High-risk health care workers at hospitals, sanatoriums, and elderly care faci...
SOUTH KOREA’S OWN COVID-19 VACCINE TO BE DEVELOPED LATE NEXT YEAR
Highlights –
- South Korea’s own COVID-19 vaccine to be developed late next year.
- South Korean Prime Minister announced the same on Thursday.
- Whereas foreign vaccines are scheduled to be administered starting early next year. ...
COVID-19 VACCINE TO BE APPROVED IN A SHORT PERIOD BY S. KOREAN GOVT.
Highlights –
- COVID-19 vaccine to be approved in a short period by S. Korean Govt.
- Around 180 days is required for a vaccine to be approved on a standard licensing procedure.
- The Ministry of Food and Drug Safety is planning to shorten ...
SOUTH KOREA LIKELY TO SIGN COVID-19 VACCINE DEAL WITH J&J JANSSEN, PFIZER
Highlights –
- South Korea likely to sign a COVID-19 vaccine deal with J&J Janssen and Pfizer.
- The South Korean health ministry said to have procured vaccine deals from four pharmaceutical companies.
- The government has set aside 1.3...
THE U.S. FDA COULD SOON MAKE THE CORONA VIRUS VACCINE AVAILABLE
Highlights
- The move is not influenced by Trump administration
- It would be done only if the benefits outweigh the risks
The United States is observing the rising number of corona virus cases. To make the v...
REMDESIVIR APPROVED BY FDA FOR ALL HOSPITALISED COVID PATIENTS
Highlights:
• Remdesivir is now approved for all the hospitalized COVID positive patients
• Earlier on FDA has approved of blood plasma treatment too
Recently, CDC revised its guideline...
DR. SCOTT GOTTLIEB: A CHANGE IN THE REQUIREMENT FOR HOME CORONA VIRUS TESTS WILL PROVE HELPFUL
Highlights
- It would give faster results
- People can accordingly take the necessary precautions
Dr. Scott Gottlieb acknowledged the new move by the Food and Drug Administration. It could en...
TRUMP TO SIGN A DEAL FOR THE PURCHASE OF 150 MILLION RAPID CORONA VIRUS TESTS
Highlights
- It will cost around $5
- It delivers result in minutes
President Donald Trump is going to make a big announcement. It is regarding the purchase of 150 million rapid corona virus tests. The test is called the Bina...
DR. SCOTT GOTTLIEB: CONVALESCENT PLASMA TREATMENT MAY BE HELPFUL BUT NOT ENTIRELY EFFECTIVE
Highlights
- In the early stages of the outbreak, convalescent plasma was used to treat corona virus patients
- It was used on a case-by-case basis
To treat coronavirus patients, the Food and Drug Administrat...
PRESIDENT TRUMP LEFT SURPRISED ON THE FDA’S HOLD ON BLOOD TREATMENT THERAPY
Highlights
- Trump insists on its use if it proves to be good
- Health officials raise concerns about data on the treatment
On the emergency use authorization for convalescent plasma therapy, the Food and Drug Administration recently pla...
GILEAD COULD GET FDA APPROVAL FOR USE OF REMDESIVIR DESPITE MIXED TRIAL RESULTS
Highlights –
- Gilead could get FDA approval for use of Remdesivir despite mixed trail results.
- The FDA had approved in May for sale of the drug to be used on an emergency basis for patients with severe COVID-19.
- The company had publis...
DR. FAUCI: CORONA VIRUS VACCINE MAY NOT BE HIGHLY EFFECTIVE
Highlights
- The corona virus vaccine shall be at least 75% effective
- 50% or 60% effective vaccine would be considered as manageable
Scientists are working hard on the development of the vaccine for the corona virus. D...
SANTEN OBTAINS US FDA ACCEPTANCE OF PMA APPLICATION FOR DE-128
HIGHLIGHTS
- Santen Pharmaceutical Co., Ltd. has submitted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
- US FDA has accepted the application from Santen.
- DE-128 is an investigational surgical glaucoma implant.
Why we don't have an antibody for Lyme illness
Lyme sickness is the most widely recognized vector-borne ailment in the United States, contaminating a huge number of individuals every year. However there's right now no antibody available that can shield people from getting this malady — an answer that would be sought after in high-ha...